Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

E I Du Pont De Nemours And Co (DD): Trian Fund Nominates Four Director Candidates After Raising Stake

Nelson Peltz‘s Trian Fund Management has recently disclosed that it has nominated four director candidates to be elected to the board of E I Du Pont De Nemours And Co (NYSE:DD) at the 2015 Annual Meeting of Stockholders. Trian Fund owns some 24.4 million shares of the company, the stake represeting around 2.7% of the company and has a value of some $1.80 billion.


Nelson Peltz is a famous activist on the Street with investors ranging from pension funds and university endowments to insurance companies. As of the end of last year, the fund owns an equity portfolio worth $9.43 billion, which contains only 11 positions mainly in consumer goods, financial and services stocks. Moreover, the fund has increased its positions in only two companies during the last quarter of 2014, one of which is E I Du Pont De Nemours And Co (NYSE:DD), in which the stake has been increased by 17.35 million shares. In this way, following the increase, E I Du Pont currently represents the largest equity position in the fund’s equity portfolio. Trian also holds some 17.87 million shares of PepsiCo, Inc. (NYSE:PEP), whose stock gained 46% over the last three years. The third-largest equity position is represented by Mondelez International Inc (NASDAQ:MDLZ), in which the fund has increased its stake by 10% on the quarter to 46.30 million shares. The stock of Mondelez gained around 30% since the fund added the company to its equity portfolio during the first quarter of 2013.

As it was mentioned earlier, Trian has substantially increased its stake in E I Du Pont De Nemours And Co (NYSE:DD) during the fourth quarter of last year, which makes the holding the largest equity investment in terms of value, amassing 19% of the 13F portfolio. Trian initiated a position in the company during the second quarter of 2013, initially holding 5.78 million shares. Meanwhile, the stock of the company gained around 30%. Moreover, following the increase, Trian has become one of the largest institutional investors holding the stock.

In this way, being an activist investor with a significant position, Trian Partners has engaged in discussions with the company regarding some issues such as a decline in earnings per share, organic revenue growth that came below its peers in five of E I Du Pont De Nemours And Co (NYSE:DD)’s seven segments, and lowering its guidance for the third year in a row.

Trian considers that the current board of DuPont has not held the management accountable for the underperformance of the company. Moreover, the investor believes that the board has been disconnected from shareholders, which is shown in the latest moves such as the spin-off of its performance chemical segment. The spin-off has been conducted with poor corporate governance, and punitive anti-takeover measures, such as a claffied board, or a high 35% threshold of stockholders to call a special meeting among others, Trian said in a press release.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.